Skip to main content

Table 3 The estimated average treatment effect of ABC based regimen on opportunistic infections at JMC

From: Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study

Treatment groupCoefficient (β)AI Robust Standard Errorsp95% CI
AZTBase Regimen
ABCATE0.01120.05660.844−0.0998, 0.1221
ATET0.02170.07500.772−0.1253, 0.1688